Briefing to the House of Commons Standing Committee on Health on Prescription Drugs
The Canadian government needs to abolish pharmaceutical price controls, increase competition amongst drug makers by allowing advertising, stop the gray market in prescription drugs from Canada to the United States, and take other steps to improve pharmaceutical regulation, according to John R. Graham, Director, Health and Pharmaceutical Policy Research at The Fraser Institute. Graham testified before the House of Commons Standing Committee on Health in Vancouver on September 29.
More from this study
Subscribe to the Fraser Institute
Get the latest news from the Fraser Institute on the latest research studies, news and events.